Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.
3.
4.

Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.

Serratì S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I, Liotta F, Annunziato F, Pucci M, Del Rosso M.

J Pathol. 2008 Apr;214(5):545-54. doi: 10.1002/path.2309.

PMID:
18189329
5.

Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells.

Zhu YM, Azahri NS, Yu DC, Woll PJ.

BMC Cancer. 2008 Jul 31;8:218. doi: 10.1186/1471-2407-8-218.

6.

Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.

Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K.

Lung Cancer. 2004 Oct;46(1):11-9.

PMID:
15364128
7.
8.

The mitogenic and anti-apoptotic activity of tumor conditioned medium on endothelium.

Li A, Li H, Zhang J, Jin G, Xiu R.

Clin Hemorheol Microcirc. 2003;29(3-4):375-82.

PMID:
14724364
9.

A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier.

Kargozaran H, Yuan SY, Breslin JW, Watson KD, Gaudreault N, Breen A, Wu MH.

Clin Exp Metastasis. 2007;24(7):495-502.

PMID:
17653824
10.

Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function.

Rouleau C, Roy A, St Martin T, Dufault MR, Boutin P, Liu D, Zhang M, Puorro-Radzwill K, Rulli L, Reczek D, Bagley R, Byrne A, Weber W, Roberts B, Klinger K, Brondyk W, Nacht M, Madden S, Burrier R, Shankara S, Teicher BA.

Mol Cancer Ther. 2006 Feb;5(2):219-29.

11.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

12.

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.

Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ.

Cancer Res. 2005 Dec 1;65(23):11001-9.

14.
15.

Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance.

Davies G, Rmali KA, Watkins G, Mansel RE, Mason MD, Jiang WG.

Int J Oncol. 2006 Nov;29(5):1311-7.

PMID:
17016666
16.

Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells.

Khodarev NN, Yu J, Labay E, Darga T, Brown CK, Mauceri HJ, Yassari R, Gupta N, Weichselbaum RR.

J Cell Sci. 2003 Mar 15;116(Pt 6):1013-22.

17.

Adhesion of nonmetastatic and highly metastatic breast cancer cells to endothelial cells exposed to shear stress.

Moss MS, Sisken B, Zimmer S, Anderson KW.

Biorheology. 1999;36(5-6):359-71.

PMID:
10818635
18.

Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.

Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S.

Cancer Lett. 2008 Mar 18;261(2):147-57. doi: 10.1016/j.canlet.2007.11.028.

PMID:
18171602
19.

A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.

Krueger P, Nitz C, Foster R, MacDonald C, Gelber O, Lalehzadeh G, Goodson R, Winter J, Gelber C.

Cancer Immunol Immunother. 2003 Jun;52(6):367-77.

PMID:
12669243
20.

Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin.

Poulsen TT, Pedersen N, Perin MS, Hansen CK, Poulsen HS.

Lung Cancer. 2005 Dec;50(3):329-37.

PMID:
16115696

Supplemental Content

Support Center